In this commentary, I highlight study findings from the 2016 Hematology meeting that may affect management of patients with myelofibrosis or polycythemia vera.
Use this online tool to compare your treatment selection for a patient with MF or PV with expert recommendations from Michael W. Deininger, MD, PhD; John Mascarenhas, MD; Ruben A. Mesa, MD; Brady L. Stein, MD, MHS; and Srdan Verstovsek, MD, PhD.
In this downloadable slideset, Srdan Verstovsek, MD, PhD, reviews key data informing optimal treatment strategies for MF and PV.
In this interactive, CME/CE-certified module, Srdan Verstovsek, MD, PhD, provides expert perspectives on key data informing optimal treatment strategies for MF and PV.
You are accessing CCO's educational content today as a Guest user.
If you would like to continue with free, full access to the CCO Web sites, including free CME/CE credits, please click the button below.